
|Articles|September 6, 2019
- September 2019 Pain Management
- Volume 85
- Issue 9
Evolving Strategies in the Management of HIV: An Update for Pharmacists
New and emerging strategies in the management of HIV
Advertisement
Faculty
Eric K. Farmer, PharmD, BCPS, AAHIVP, HIV Clinical Pharmacist, Indiana University Health, LifeCare Clinic; Indianapolis, Indiana
Educational Objectives
At the completion of this activity, the participant will be able to:
- Explore the burden of HIV and evolving treatment strategies
- Identify current guideline recommendations and therapies, as well as emerging treatment options that may be used to optimize the management of patients with or at risk for HIV
- Examine strategies that pharmacists may employ to improve patient adherence, treatment satisfaction, and overall outcomes
Target audience: Pharmacists
Activity type: Application
Release date: September 16, 2019
Expiration date: September 16, 2020
Estimated time to complete activity: 2.5 hours
Fee: This lesson is offered for free at
Articles in this issue
over 6 years ago
Keep an Eye on Protein Kinase Inhibitorsover 6 years ago
OTC Focus Case Studies: Painover 6 years ago
What Are the Options for Treating Pain?over 6 years ago
Education, Law Enforcement, and Treatment Programs Are Keyover 6 years ago
Dispensing Mistakes Can Happen to Pets, Tooover 6 years ago
MRPs Are Both a Blessing and a Curseover 6 years ago
Pharmacists Can Provide Optimal Migraine Treatmentsover 6 years ago
Melrose Pharmacy Offers a Unique Feelover 6 years ago
Topical Analgesics Provide Pain Reliefover 6 years ago
Case Studies (September 2019)Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
4
ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D
5





































































































































